Clinical studies have shown that rose hip powder (RHP) exerts beneficial effects in OA patients. Thus, substances contained in proprietary RHP should have an effect on parameters involved in disease initiation and progression. Until now only one of its constituents -GOPOwas shown to inhibit the migration of polymorphonuclear leukocytes. In this study various in vitro effects of RHP and GOPO related to inflammatory processes, erosion of cartilage tissue and chondro-protection were evaluated. Methods: Anti-inflammatory effects were measured in LPS-activated macrophage RAW264.7 cells. Cells were cultured for 4−24 hrs with different doses of RHP or GOPO. Gene expression was quantified by RT-PCR; production of inflammatory mediators like PGE 2 was measured by ELISA and nitric oxide determined by the Griess reaction. Substances were tested on primary human chondrocytes (without and with concomitant activation of chondrocytes by Il-1beta) and the expression of anabolic and catabolic genes was monitored by real-time PCR Results: Rose hip and GOPO inhibit the production of NO (IC 50 816±38 mg/L and 37.0±6.0 mmol/L, respectively). We observed weaker effects on PGE 2 production (IC 50 594±43 mg/L and >50 mmol/L). Expression of inflammatory genes like iNOS, Il-1alpha, MMP-9 was significantly reduced by GOPO, but to a lower degree by RHP. In activated chondrocytes, GOPO decreased the expression of catabolic genes (e.g. ADAMTS-4, MMP-1, MMP-13), interleukins or chemokines (IL1-alpha, Il-8, CC5), whereas the expression of collagen or aggreccan genes was slightly increased. We observed a GOPO-dependent increased expression level of SOX-5 or SOX-9. RHP had similar although weaker effects. On a stoichiometric basis, however, the GOPO contents of RHP does not fully account for the observed biological effects and thus infers on the presence of additional anti-inflammatory and chondro-protective substances in RHP.
. Sulf-1 and Sulf-2 mRNA expression in articular cartilage were significantly higher in the OA group (Sulf-1: P = 0.001, Sulf-2: P = 0.019). Figure 2 . The OA middle zone had significantly more Sulf-1 positive cells than the other zones (*: P < 0.01). Sulf-2 expression in normal cartilage was significantly higher than Sulf-1 (P = 0.02).
Results:
Sulf-1 and Sulf-2 mRNA expression in older OA donors (n = 8; 49−68 years old; Mankin score: 7−10) was significantly higher than in young donors (n = 8; 19−37 years old; Mankin score: 0−2 points) as determined by real-time PCR (Figure 1 ). Immunohistochemistry showed that young and old normal samples had only a few Sulf positive cells in the superficial zone and no positive cells in the middle and deep zone. In general, the expression of Sulf-2 appeared more intense than Sulf-1 in normal cartilage. In OA cartilage, many positive cells were detected, especially in chondrocyte clusters. The normal areas had only 18.5% Sulf-1 positive and 31.9% Sulf-2 positive cells in the superficial zone, which was greater than in normal cartilage. On the other hand, OA areas had 75.3% Sulf-1 positive and 73.2% Sulf-2 positive cells. Figure 2 shows quantitative analysis of the zonal distribution of Sulf-1 and Sulf-2 expressing cells in eight normal (17−37 years old) and eight OA donors (43−82 years old). The middle zone in OA cartilage had significantly more positive cells than normal (*P < 0.01). Moreover, the number of Sulf-2 positive cells in superficial and middle zone was greater than Sulf-1 expressing cells (P = 0.02). Western blotting revealed higher levels of Sulf-1 and Sulf-2 protein in OA cartilage as compared to normal tissue. Temporomandibular joints (TM) and knee joints from normal C57Bl/6J mice (n = 14) showed only few cells were positive for Sulf-1 but Sulf-2 positive cells at 6 months of age. There was a marked increase in Sulf-2 expression at 9 months and in Sulf-1 expression at 12 months, associated with the presence of early OA-like lesions.
